Cassava Sciences Inc vs JetBlue Airways Corporation — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: JetBlue Airways Corporation is far larger — about 45.9× Cassava Sciences Inc's market cap, and JetBlue Airways Corporation is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | JBLU | |
|---|---|---|
Market Cap | $47.75M | $2.19B |
Sector | Health | Industrials |
52-Week High | $4.64 | $6.46 |
52-Week Low | $0.87 | $4.03 |
Enterprise Value | -$34.93M | $9.56B |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →